Skip to main content
OpenTrials

Clinical trial condition

Exudative Macular Degeneration

Explore clinical trials studying Exudative Macular Degeneration. Study availability and eligibility vary by location and protocol.

9 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Exudative Macular Degeneration trial results

Completed

Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD)

NCT01535950

Conditions
Exudative Macular Degeneration, Eye Diseases, Macular Degeneration, +4 more
Locations
  • Novartis Investigative Site Tucson, Arizona, United States
  • Novartis Investigative Site Torrance, California, United States
  • Novartis Investigative Site Fort Myers, Florida, United States
  • Novartis Investigative Site Baltimore, Maryland, United States
View Trial Details
Completed

Intravitreal tPA and C3F8 for the Treatment of Submacular Haemorrhage as a Complication of Neovascular AMD

NCT01835067

Conditions
Exudative Macular Degeneration, Eye Diseases, Eye Hemorrhage, +8 more
Locations
  • Maidstone Hospital Maidstone, Kent, United Kingdom
  • Sunderland Eye Infimary Sunderland, Tyne and Wear, United Kingdom
  • Hull & East Yorkshire Hospital NHS Trust Hull, United Kingdom
  • King's College Hospital NHS Foundation Trust London, United Kingdom
View Trial Details
Completed

Pilot Study of X-82 in Patients With Wet AMD

NCT01674569

Conditions
Exudative Macular Degeneration, Eye Diseases, Macular Degeneration, +3 more
Locations
  • Retina Vitreous Associates Medical Group Beverly Hills, California, United States
  • New England Retina Associates New London, Connecticut, United States
  • Elman Retina Group Baltimore, Maryland, United States
  • Retina Research Institute of Texas Abilene, Texas, United States
View Trial Details

Related conditions